Home / Bio-technology / Europe Genome Editing/Genome Engineering Market Report 2021

Europe Genome Editing/Genome Engineering Market Report 2021

  • Id : RNR-11580
  • Category : Bio-technology
  • Publish Date : Oct 2016
  • Publisher : S&P Consulting
  • Pages : 120
  • Format : PDF
License Type

Description
Sales, means the sales volume of Genome Editing/Genome Engineering
Revenue, means the sales value of Genome Editing/Genome Engineering

This report studies sales (consumption) of Genome Editing/Genome Engineering in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
    Thermo Fisher Scientific, Inc. (U.S.)
    Merck KGAA (Germany)
    Horizon Discovery Group Plc (U.K.)
    Genscript Biotech Corporation (U.S.)
    Sangamo Biosciences, Inc. (U.S.)
    Integrated DNA Technologies, Inc (U.S.)
    Lonza Group Ltd. (Switzerland)
    New England Biolabs, Inc. (U.S.)
    Origene Technologies, Inc. (U.S.)
    Transposagen Biopharmaceuticals, Inc. (U.S.)

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Genome Editing/Genome Engineering in these countries, from 2011 to 2021 (forecast), like
    Germany
    France
    UK
    Russia
    Italy
    Spain
    Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
    CRISPR
    TALEN
    ZFN
    Antisense
    Other Technologies

Split by application, this report focuses on sales, market share and growth rate of  Genome Editing/Genome Engineering in each application, can be divided into
    Cell Line Engineering
    Animal Genetic Engineering
    Plant Genetic Engineering
    Other Applications